Key result
HF events in HFrEF are linked to ~4-fold steeper preceding eGFR decline.
Why the study?
Are steeper declines in eGFR associated with subsequent HF-related events in patients with HFrEF?
Cohort (n=10,635)
Yes
Are steeper declines in eGFR associated with subsequent HF-related events in patients with HFrEF?
Monitoring eGFR slopes rather than absolute cut-offs may allow for early detection of impending heart failure events in patients with HFrEF.
Answers are grounded in this paper and cite their sources.
May support eGFR slope monitoring for HFrEF risk stratification; leaves open prospective validation before practice change.
BACKGROUND AND AIMS: Worsening kidney function is a key prognostic factor in heart failure (HF) with reduced ejection fraction (HFrEF). However, associations between kidney function trajectories and HF-related events remain unclear. METHODS: Longitudinal changes in estimated glomerular filtration rate (eGFR) before and after a HF-related event, defined as HF hospitalization or HF death, were examined using individual patient data from two clinical trials (EPHESUS and EMPHASIS-HF) and a real-world cohort (BARCELONA). RESULTS: HF-related events occurred in 14.1% of 8587 patients [EPHESUS/EMPHASIS-HF; median follow-up 17.1 (12.4-22.7) months] and 33.8% of 2048 patients [BARCELONA; median 47.0 (18.8-90.6) months]. In EPHESUS and EMPHASIS-HF, patients who experienced an HF-related event had a steeper decline in eGFR in the year preceding the event (average -4.83 mL/min/1.73 m²/year) compared with those who did not have an HF-related event (-1.18 mL/min/1.73 m²/year). Over the 1 year following an HF-related event, eGFR continued to decline, though at a slower rate (average -3.45 mL/min/1.73 m²/year). Similar kidney function trajectories were observed in BARCELONA (average eGFR decline -1.35 mL/min/1.73 m²/year in patients without HF event vs -5.77 mL/min/1.73 m²/year 1 year before an event and -3.04 mL/min/1.73 m²/year over the year after an event). Worsening New York Heart Association class paralleled steeper eGFR decline prior to HF events. CONCLUSIONS: In HFrEF, kidney function decline may precede a HF hospitalization or death by up to 1 year, linking to symptomatic congestion. Monitoring eGFR slopes rather than relying solely on specific cut-off values may allow early detection of at-risk patients.
No takes yet. Share an insight, caveat, or question.
Kobayashi et al. (2025) conducted a cohort in Heart failure with reduced ejection fraction (HFrEF) (n=10,635). HF-related event (HF hospitalization or HF death) vs. No HF-related event was evaluated on eGFR decline in the year preceding an HF-related event (mL/min/1.73 m²/year). In patients with HFrEF, experiencing an HF-related event was preceded by a steeper decline in eGFR compared to those without an event.
Synapse has enriched 10 related papers. Consider them for comparative context: